Filing Details

Accession Number:
0001209191-23-056904
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-29 16:31:29
Reporting Period:
2023-11-27
Accepted Time:
2023-11-29 16:31:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1658247 Crinetics Pharmaceuticals Inc. CRNX Pharmaceutical Preparations (2834) 263744114
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1886575 F. Stephen Betz C/O Crinetics Pharmaceuticals, Inc.
10222 Barnes Canyon Road, Bldg 2
San Diego CA 92121
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-11-27 3,000 $31.84 85,298 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan.
  2. The common stock was sold by the Reporting Person in open market transactions on the transaction date with a volume weighted average sales price of $31.84 per share. The range of sales prices on the transaction date was $31.41 to $31.94 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
  3. Includes 1,419 shares acquired under the Issuer's Employee Stock Purchase.